Nivolumab for unresectable cutaneous epithelial malignancies: an open-label, single-arm, multi-centre, phase II trial (NMSC-PD1)
纳武利尤单抗治疗不可切除的皮肤上皮恶性肿瘤：一项开放标签、单臂、多中心 II 期试验 (NMSC-PD1)
期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-026-15829-2
Nakamura, Yoshio; Yamazaki, Naoya; Namikawa, Kenjiro; Uchi, Hiroshi; Mori, Shoichiro; Ogawa-Momohara, Mariko; Fujimura, Taku; Takenouchi, Tatsuya; Kurimoto, Mana; Yamamoto, Yuki; Otsuka, Atsushi; Kabashima, Kenji; Fusumae, Takayuki; Hirai, Ikuko; Tanese, Keiji; Saito, Yasuko; Amagai, Masayuki; Takemura, Ryo; Sato, Yasunori; Funakoshi, Takeru
